NM_000268.4(NF2):c.1237A>G (p.Lys413Glu) AND Neurofibromatosis, type 2

Clinical significance:Uncertain significance (Last evaluated: Aug 4, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_000268.4(NF2):c.1237A>G (p.Lys413Glu)]

NM_000268.4(NF2):c.1237A>G (p.Lys413Glu)

NF2:NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_000268.4(NF2):c.1237A>G (p.Lys413Glu)
  • NC_000022.11:g.29673383A>G
  • NG_009057.1:g.74828A>G
  • NM_000268.4:c.1237A>GMANE SELECT
  • NM_016418.5:c.1237A>G
  • NM_181825.3:c.1237A>G
  • NM_181828.3:c.1111A>G
  • NM_181829.3:c.1114A>G
  • NM_181830.3:c.988A>G
  • NM_181831.3:c.988A>G
  • NM_181832.3:c.1237A>G
  • NM_181833.3:c.448-21369A>G
  • NP_000259.1:p.Lys413Glu
  • NP_057502.2:p.Lys413Glu
  • NP_861546.1:p.Lys413Glu
  • NP_861966.1:p.Lys371Glu
  • NP_861967.1:p.Lys372Glu
  • NP_861968.1:p.Lys330Glu
  • NP_861969.1:p.Lys330Glu
  • NP_861970.1:p.Lys413Glu
  • LRG_511t2:c.1237A>G
  • LRG_511:g.74828A>G
  • LRG_511p2:p.Lys413Glu
  • NC_000022.10:g.30069372A>G
  • NR_156186.2:n.1719A>G
Protein change:
dbSNP: rs766974263
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_181833.3:c.448-21369A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000268.4:c.1237A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_016418.5:c.1237A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181825.3:c.1237A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181828.3:c.1111A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181829.3:c.1114A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181830.3:c.988A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181831.3:c.988A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181832.3:c.1237A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_156186.2:n.1719A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]


Neurofibromatosis, type 2 (NF2)
NF 2; Neurofibromatosis central type; Acoustic schwannomas bilateral; See all synonyms [MedGen]
MONDO: MONDO:0007039; MedGen: C0027832; Orphanet: 637; OMIM: 101000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV001542335Invitaecriteria provided, single submitter
Uncertain significance
(Aug 4, 2020)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Eleven novel mutations in the NF2 tumour suppressor gene.

Bourn D, Evans G, Mason S, Tekes S, Trueman L, Strachan T.

Hum Genet. 1995 May;95(5):572-4.

PubMed [citation]
See all PubMed Citations (7)

Details of each submission

From Invitae, SCV001542335.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)


This sequence change replaces lysine with glutamic acid at codon 413 of the NF2 protein (p.Lys413Glu). The lysine residue is moderately conserved and there is a small physicochemical difference between lysine and glutamic acid. This variant is present in population databases (rs766974263, ExAC 0.02%). This variant has been observed in individual(s) with clinical features of neurofibromatosis type 2 (PMID: 7759081). This variant has been reported to have conflicting or insufficient data to determine the effect on NF2 protein function (PMID: 11535133, 24309211, 24595234, 9931334, 9466988). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 27, 2021

Support Center